Share

April 2015; 2 (2) ArticleOpen Access

High natural killer cell number might identify stroke patients at risk of developing infections

Sylvie De Raedt, Aurelie De Vos, Anne-Marie Van Binst, Marc De Waele, Danny Coomans, Ronald Buyl, Jacques De Keyser
First published February 12, 2015, DOI: https://doi.org/10.1212/NXI.0000000000000071
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
677

Share

Article Information

vol. 2 no. 2 e71
DOI: 
https://doi.org/10.1212/NXI.0000000000000071
PubMed: 
25738168
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Online ISSN: 
2332-7812
History: 
  • Received June 5, 2014
  • Accepted in final form December 30, 2014
  • First Published February 12, 2015.
Copyright & Usage: 
© 2015 American Academy of Neurology This is an open access article distributed under the terms of the Creative Commons Attribution-Noncommercial No Derivative 3.0 License, which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially.

Author Disclosures

    1. Sylvie De Raedt, MD,
    2. Aurelie De Vos, MD,
    3. Anne-Marie Van Binst, MD,
    4. Marc De Waele, MD, PhD,
    5. Danny Coomans, MD, PhD,
    6. Ronald Buyl, MD, PhD and
    7. Jacques De Keyser, MD, PhD
  1. Sylvie De Raedt, MD,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. Unrestricted grant from Astra Zeneca of 50.000 euro/year for 3 years for studying the role of the sympathetic system in acute stroke (bottom-up proposal).

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Aurelie De Vos, MD,
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Anne-Marie Van Binst, MD,
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. Marc De Waele, MD, PhD,
    5. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  5. Danny Coomans, MD, PhD,
    6. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  6. Ronald Buyl, MD, PhD and
    7. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  7. Jacques De Keyser, MD, PhD
    8. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. Unrestricted grant from Astra Zeneca of 50.000 euro/year for 3 years for studying the role of the sympathetic system in acute stroke (bottom-up proposal).

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From the Departments of Neurology (S.D.R., A.D.V., J.D.K.), Radiology (A.-M.V.B.), Hematology (M.D.W.), and Biostatistics and Medical Informatics (D.C., R.B.), Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel (VUB), Brussels, Belgium; and Department of Neurology (J.D.K.), Universitair Medisch Centrum Groningen, the Netherlands.
  1. Correspondence to Dr. De Raedt: sylvie.deraedt{at}uzbrussel.be
View Full Text

Article usage

Article usage: March 2015 to May 2022

AbstractFullPdfSource
Feb 2015971110Highwire
Mar 20151584315Highwire
Mar 201504126pmc
Apr 20151902420Highwire
Apr 20150249pmc
May 2015528310Highwire
May 20150168pmc
Jun 2015542810Highwire
Jun 20150126pmc
Jul 201550813Highwire
Jul 2015051pmc
Aug 20157089Highwire
Aug 20150109pmc
Sep 201539161Highwire
Sep 20150103pmc
Oct 2015191311Highwire
Oct 2015071pmc
Nov 201518121Highwire
Nov 20150104pmc
Dec 201522173Highwire
Dec 2015083pmc
Jan 20161691Highwire
Jan 2016041pmc
Feb 201619143Highwire
Feb 2016073pmc
Mar 20161097Highwire
Mar 2016063pmc
Apr 20162983Highwire
Apr 2016062pmc
May 20162751Highwire
May 2016041pmc
Jun 201640114Highwire
Jun 2016010pmc
Jul 20162762Highwire
Jul 2016011pmc
Aug 20162181Highwire
Aug 2016072pmc
Sep 20162250Highwire
Sep 2016071pmc
Oct 20162481Highwire
Oct 2016043pmc
Nov 201615104Highwire
Nov 2016011pmc
Dec 201612103Highwire
Dec 2016042pmc
Jan 20172172Highwire
Jan 2017010pmc
Feb 20171751Highwire
Feb 20170104pmc
Mar 201715101Highwire
Mar 2017063pmc
Apr 201714103Highwire
Apr 2017221pmc
May 20171493Highwire
May 2017469pmc
Jun 2017900Highwire
Jun 2017210pmc
Jul 20179133Highwire
Jul 2017435pmc
Aug 20171183Highwire
Aug 2017245pmc
Sep 2017972Highwire
Sep 2017485pmc
Oct 2017510Highwire
Oct 201741318pmc
Nov 2017842Highwire
Nov 201711015pmc
Dec 2017163Highwire
Jan 20182104Highwire
Feb 20180168Highwire
Mar 20183206Highwire
Apr 20181112Highwire
Apr 2018133pmc
May 20184415Highwire
Jun 20180154Highwire
Jun 2018233pmc
Jul 20181214Highwire
Aug 20181233Highwire
Aug 2018022pmc
Sep 20181286Highwire
Oct 20182356Highwire
Nov 20181882Highwire
Dec 201801527Highwire
Jan 201921353Highwire
Feb 201941121Highwire
Mar 20194544Highwire
Apr 20191226Highwire
May 20193168Highwire
Jun 20193314Highwire
Jul 20193255Highwire
Aug 20191115Highwire
Sep 2019294Highwire
Oct 20191221Highwire
Nov 20191163Highwire
Dec 20190253Highwire
Jan 20201246Highwire
Feb 20201135Highwire
Mar 202022411Highwire
Apr 20200116Highwire
May 20200101Highwire
Jun 20200134Highwire
Jul 2020294Highwire
Aug 2020383Highwire
Sep 202061510Highwire
Oct 20202134Highwire
Nov 202021114Highwire
Dec 20203133Highwire
Jan 20212179Highwire
Feb 20211105Highwire
Mar 20214119Highwire
Apr 20214146Highwire
May 2021276Highwire
Jun 20214135Highwire
Jul 202151626Highwire
Aug 202122817Highwire
Sep 2021289Highwire
Oct 202142220Highwire
Nov 202101417Highwire
Dec 20212185Highwire
Jan 20224148Highwire
Feb 202241716Highwire
Mar 20226248Highwire
Apr 20221125Highwire
May 202241612Highwire

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top

Related Articles

  • No related articles found.

Topics Discussed

Alert Me

Advertisement